Cargando…

Valuable clinical indicators for identifying infantile-onset inflammatory bowel disease patients with monogenic diseases

BACKGROUND: Infantile-onset inflammatory bowel disease (IO-IBD) occurs in very young children and causes severe clinical manifestations, which has poor responses to traditional inflammatory bowel disease (IBD) treatments. At present, there are no simple and reliable laboratory indicators for early s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Wen, Yu, Yi, Xu, Xu, Wang, Xin-Qiong, Huang, Jie-Bin, Xu, Chun-Di, Xiao, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789064/ https://www.ncbi.nlm.nih.gov/pubmed/33505153 http://dx.doi.org/10.3748/wjg.v27.i1.92

Ejemplares similares

Childhood-onset inflammatory bowel diseases associated with mutation of Wiskott-Aldrich syndrome protein gene
por: Ohya, Takashi, et al.
Publicado: (2017)

Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort
por: Lee, Way Seah, et al.
Publicado: (2016)

Higher Morbidity of Monogenic Inflammatory Bowel Disease Compared to the Adolescent Onset Inflammatory Bowel Disease
por: Kim, Kwang Yeon, et al.
Publicado: (2018)

Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
por: Halling, Morten L, et al.
Publicado: (2017)

Serological investigation of IgG and IgE antibodies against food antigens in patients with inflammatory bowel disease
por: Wang, Hai-Yang, et al.
Publicado: (2019)

Role of telomere shortening in anticipation of inflammatory bowel disease
por: Truta, Brindusa, et al.
Publicado: (2020)

Pharmacologic Management of Monogenic and Very Early Onset Inflammatory Bowel Diseases
por: Levine, Anne E., et al.
Publicado: (2023)

Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease
por: Ma, Hai-Qin, et al.
Publicado: (2018)

Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide, population-based study
por: Lee, Jooyoung, et al.
Publicado: (2019)

Essential role of small bowel capsule endoscopy in reclassification of colonic inflammatory bowel disease type unclassified
por: Monteiro, Sara, et al.
Publicado: (2017)

Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease
por: Horvat, Natally, et al.
Publicado: (2016)

Frequency, types, and treatment of anemia in Turkish patients with inflammatory bowel disease
por: Bengi, Göksel, et al.
Publicado: (2018)

Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease
por: Gordon, Benjamin Langan, et al.
Publicado: (2022)

Major depressive disorders in patients with inflammatory bowel disease and rheumatoid arthritis
por: Haider, Maryam Bilal, et al.
Publicado: (2023)

Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting
por: Berkowitz, Joshua C, et al.
Publicado: (2018)

Capsule endoscopy and single-balloon enteroscopy in small bowel diseases: Competing or complementary?
por: Ma, Jing-Jing, et al.
Publicado: (2016)

Predictors of vitamin D deficiency in inflammatory bowel disease and health: A Mississippi perspective
por: Pallav, Kumar, et al.
Publicado: (2017)

Advanced Understanding of Monogenic Inflammatory Bowel Disease
por: Nambu, Ryusuke, et al.
Publicado: (2021)

Prevalence, phenotype and medication for the pediatric inflammatory bowel disease population of a state in Southeastern Brazil
por: Martins, Adalberta Lima, et al.
Publicado: (2022)

Autosomal recessive 333 base pair interleukin 10 receptor alpha subunit deletion in very early-onset inflammatory bowel disease
por: Lv, Jia-Jia, et al.
Publicado: (2021)

Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis
por: Hoffmann, Peter, et al.
Publicado: (2020)

Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study
por: Choi, You-Jung, et al.
Publicado: (2019)

One-half layer pancreaticojejunostomy with the rear wall of the pancreas reinforced: A valuable anastomosis technique
por: Wei, Jin-Ping, et al.
Publicado: (2022)

Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
por: Lew, Daniel, et al.
Publicado: (2017)

Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease
por: Bajer, Lukas, et al.
Publicado: (2018)

Apolipoprotein E variants correlate with the clinical presentation of paediatric inflammatory bowel disease: A cross-sectional study
por: Glapa-Nowak, Aleksandra, et al.
Publicado: (2021)

Positive correlation between latent Epstein-Barr virus infection and severity of illness in inflammatory bowel disease patients
por: Wei, Hong-Tao, et al.
Publicado: (2023)

Bowel inflammatory presentations on computed tomography in adult patients with severe aplastic anemia during flared inflammatory episodes
por: Zhao, Xi-Chen, et al.
Publicado: (2023)

Correlation between thrombopoietin and inflammatory factors, platelet indices, and thrombosis in patients with sepsis: A retrospective study
por: Xu, Wan-Hua, et al.
Publicado: (2022)

Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease
por: Rubio, Marrieth G, et al.
Publicado: (2019)

Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study
por: Park, Seona, et al.
Publicado: (2018)

Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy
por: Rubin, Samuel J S, et al.
Publicado: (2022)

Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease
por: Spekhorst, Lieke M, et al.
Publicado: (2017)

Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease
por: Yao, Ling-Ya, et al.
Publicado: (2022)

Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease
por: Zeng, Jing, et al.
Publicado: (2020)

The Valuable Role of Endoscopy in Inflammatory Bowel Disease
por: Hamilton, Matthew J.
Publicado: (2012)

Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn’s disease under infliximab therapy
por: Cao, Wan-Ting, et al.
Publicado: (2022)

High prevalence of cholestasis, with increased conjugated bile acids in inflammatory bowel diseases patients
por: Girardin, Marc, et al.
Publicado: (2018)

Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification
por: Lopez-Siles, Mireia, et al.
Publicado: (2020)

Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability
por: Bohra, Anuj, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bv526ivku19mqr5rlihmoil3bl